Urology
Volume 69, Issue 3 , Pages 485-490 , March 2007

Invasively Estimated International Continence Society Obstruction Classification Versus Noninvasively Assessed Bladder Outlet Obstruction Probability in Treatment Recommendation for LUTS Suggestive of BPH

  • Joost L. Boormans

      Affiliations

    • Department of Urology, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Ger E.P.M. van Venrooij

      Affiliations

    • Department of Urology, University Medical Center, Utrecht, The Netherlands
    • Corresponding Author InformationReprint requests: Ger E. P. M. van Venrooij, Ph.D., Wethouder Schaaplaan 33, 3981 GP Bunnik, The Netherlands.
    • ,
  • Tom A. Boon

      Affiliations

    • Department of Urology, University Medical Center, Utrecht, The Netherlands

Received 23 May 2006 ,Accepted 24 October 2006.

References 

  1. International Scientific Committee. Recommendations of the International Scientific Committee: evaluation and treatment of lower urinary tract symptoms (LUTS) in older men. In:  Chatelain C,  Denis L,  Foo KT, et al. editor. Benign Prostatic Hyperplasia: Fifth International Consultation on Benign Prostatic Hyperplasia (BPH). Plymouth, UK: Plymbridge Distributors; 2001;p. 519–534
  2. Rosier PF, de Wildt MJ, Wijkstra H, et al. Clinical diagnosis of bladder outlet obstruction in patients with benign prostatic enlargement and lower urinary tract symptoms: development and urodynamic validation of a clinical prostate score for the objective diagnosis of bladder outlet obstruction. J Urol. 1996;155:1649–1654
  3. Schacterle RS, Sullivan MP, Yalla SV. Combinations of maximum urinary flow rate and American Urological Association symptom index that are more specific for identifying obstructive and non-obstructive prostatism. Neurourol Urodyn. 1996;15:459–470
  4. Steele GS, Sullivan MP, Sleep DJ, et al. Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms. J Urol. 2000;164:344–348
  5. Ockrim JL, Laniado ME, Patel A, et al. A probability based system for combining simple office parameters as a predictor of bladder outflow obstruction. J Urol. 2001;166:2221–2225
  6. Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology. 1999;54:90–96
  7. van Venrooij GE, Eckhardt MD, Boon TA. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia. Urology. 2004;63:476–480
  8. Lowe FC, Batista J, Berges R, et al. Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): a systematic analysis of expert opinion. Prostate Cancer Prostatic Dis. 2005;8:206–209
  9. Speakman M, Batista J, Berges R, et al. Integrating risk profiles for disease progression in the treatment choice for patients with lower urinary tract symptoms/benign prostatic hyperplasia: a combined analysis of external evidence and clinical expertise. Prostate Cancer Prostatic Dis. 2005;8:369–374
  10. Stoevelaar HJ, van de Beek C, Casparie AF, et al. Treatment choice for benign prostatic hyperplasia: a matter of urologist preference?. J Urol. 1999;161:133–138
  11. American Society of Anesthesiologists. New classification of physical status. Anesthesiology. 1963;24:111
  12. Abrams P, Griffiths D, Höfner K, et al. The urodynamic assessment of lower urinary tract symptoms. In:  Chatelain C,  Denis L,  Foo KT, et al. editor. Benign Prostatic Hyperplasia: Fifth International Consultation on Benign Prostatic Hyperplasia (BPH). Plymouth, UK: Plymbridge Distributors; 2001;p. 229–281
  13. Griffiths D, Höfner K, van Mastrigt R, et al. Standardization of terminology of lower urinary tract function: pressure-flow studies of voiding, urethral resistance, and urethral obstruction. Neurourol Urodyn. 1997;16:1–18
  14. Gisolf KW, van Venrooij GE, Eckhardt MD, et al. Analysis and reliability of data from 24-h frequency-volume charts in men with lower urinary tract symptoms due to benign prostatic hyperplasia. Eur Urol. 2000;38:45–52
  15. Barry MJ, Fowler FJ, O’Leary MP, et al. the Measurement Committee of the American Urological Association The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–1557
  16. Fleiss JL. Measuring nominal scale agreement among many raters. Psychological Bull. 1971;76:378–382
  17. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–174

PII: S0090-4295(06)02453-8

doi: 10.1016/j.urology.2006.10.039

Urology
Volume 69, Issue 3 , Pages 485-490 , March 2007

Article Tools